Format
Sort by
Items per page

Send to

Choose Destination

Best matches for resveratrol breast cancer:

Search results

Items: 1 to 20 of 555

1.

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts.

García-Quiroz J, García-Becerra R, Santos-Cuevas C, Ramírez-Nava GJ, Morales-Guadarrama G, Cárdenas-Ochoa N, Segovia-Mendoza M, Prado-Garcia H, Ordaz-Rosado D, Avila E, Olmos-Ortiz A, López-Cisneros S, Larrea F, Díaz L.

Cancers (Basel). 2019 Nov 6;11(11). pii: E1739. doi: 10.3390/cancers11111739.

2.

Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer.

Muniraj N, Siddharth S, Sharma D.

Cancers (Basel). 2019 Oct 15;11(10). pii: E1563. doi: 10.3390/cancers11101563. Review.

3.

Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer.

Jaskulski S, Jung AY, Huebner M, Poschet G, Hell R, Hüsing A, Gonzalez-Maldonado S, Behrens S, Obi N, Becher H, Chang-Claude J.

Nutr Cancer. 2019 Oct 16:1-15. doi: 10.1080/01635581.2019.1672762. [Epub ahead of print]

PMID:
31617773
4.

Chemoprevention of Prostate Cancer by Natural Agents: Evidence from Molecular and Epidemiological Studies.

Mokbel K, Wazir U, Mokbel K.

Anticancer Res. 2019 Oct;39(10):5231-5259. doi: 10.21873/anticanres.13720. Review.

PMID:
31570421
5.

Increase in fatty acids and flotillins upon resveratrol treatment of human breast cancer cells.

Gomes L, Sorgine M, Passos CLA, Ferreira C, de Andrade IR, Silva JL, Atella GC, Mermelstein CS, Fialho E.

Sci Rep. 2019 Sep 27;9(1):13960. doi: 10.1038/s41598-019-50416-5.

6.

Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.

Szaefer H, Licznerska B, Cykowiak M, Baer-Dubowska W.

Pharmacol Rep. 2019 Aug 14;71(6):1001-1005. doi: 10.1016/j.pharep.2019.08.005. [Epub ahead of print]

PMID:
31561186
7.

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity.

Zhang L, Zhu K, Zeng H, Zhang J, Pu Y, Wang Z, Zhang T, Wang B.

Int J Nanomedicine. 2019 Jul 31;14:6061-6071. doi: 10.2147/IJN.S211130. eCollection 2019.

8.

Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.

Fan C, Kong F, Shetti D, Zhang B, Yang Y, Wei K.

Biochem Biophys Res Commun. 2019 Nov 5;519(2):378-384. doi: 10.1016/j.bbrc.2019.09.016. Epub 2019 Sep 10.

PMID:
31519327
9.

Vitisin B as a novel fatty acid synthase inhibitor induces human breast cancer cells apoptosis.

Wang X, Jiang B, Lv H, Liang Y, Ma X.

Am J Transl Res. 2019 Aug 15;11(8):5096-5104. eCollection 2019.

10.

Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.

Shukla S, Penta D, Mondal P, Meeran SM.

Adv Exp Med Biol. 2019;1152:293-310. doi: 10.1007/978-3-030-20301-6_16. Review.

PMID:
31456191
11.

Conjugated Physiological Resveratrol Metabolites Induce Senescence in Breast Cancer Cells: Role of p53/p21 and p16/Rb Pathways, and ABC Transporters.

Giménez-Bastida JA, Ávila-Gálvez MÁ, Espín JC, González-Sarrías A.

Mol Nutr Food Res. 2019 Aug 22:e1900629. doi: 10.1002/mnfr.201900629. [Epub ahead of print]

PMID:
31441212
12.

A novel compound, ferulic acid-bound resveratrol, induces the tumor suppressor gene p15 and inhibits the three-dimensional proliferation of colorectal cancer cells.

Sawata Y, Matsukawa T, Doi S, Tsunoda T, Arikawa N, Matsunaga N, Ohnuki K, Shirasawa S, Kotake Y.

Mol Cell Biochem. 2019 Dec;462(1-2):25-31. doi: 10.1007/s11010-019-03606-8. Epub 2019 Aug 22.

PMID:
31440879
13.

Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.

González-González L, González-Ramírez R, Flores A, Avelino-Cruz JE, Felix R, Monjaraz E.

Oncology. 2019 Aug 20:1-10. doi: 10.1159/000501802. [Epub ahead of print]

PMID:
31430760
14.

Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.

Thipe VC, Panjtan Amiri K, Bloebaum P, Raphael Karikachery A, Khoobchandani M, Katti KK, Jurisson SS, Katti KV.

Int J Nanomedicine. 2019 Jun 18;14:4413-4428. doi: 10.2147/IJN.S204443. eCollection 2019.

15.

Multi-Modulation of Doxorubicin Resistance in Breast Cancer Cells by Poly(l-histidine)-Based Multifunctional Micelles.

Jia L, Jia N, Gao Y, Hu H, Zhao X, Chen D, Qiao M.

Pharmaceutics. 2019 Aug 2;11(8). pii: E385. doi: 10.3390/pharmaceutics11080385.

16.

Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.

Beetch M, Lubecka K, Shen K, Flower K, Harandi-Zadeh S, Suderman M, Flanagan JM, Stefanska B.

Mol Nutr Food Res. 2019 Oct;63(19):e1801386. doi: 10.1002/mnfr.201801386. Epub 2019 Jul 31.

PMID:
31327173
17.

Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines.

Chatterjee B, Ghosh K, Kanade SR.

Biofactors. 2019 Sep;45(5):818-829. doi: 10.1002/biof.1544. Epub 2019 Jul 17.

PMID:
31317586
18.

Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.

Chen KY, Chen CC, Chang YC, Chang MC.

PLoS One. 2019 Jul 16;14(7):e0219317. doi: 10.1371/journal.pone.0219317. eCollection 2019.

19.

Resveratrol-Induced Temporal Variation in the Mechanical Properties of MCF-7 Breast Cancer Cells Investigated by Atomic Force Microscopy.

Iturri J, Weber A, Moreno-Cencerrado A, Vivanco MD, Benítez R, Leporatti S, Toca-Herrera JL.

Int J Mol Sci. 2019 Jul 3;20(13). pii: E3275. doi: 10.3390/ijms20133275.

20.

Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.

Poonia N, Kaur Narang J, Lather V, Beg S, Sharma T, Singh B, Pandita D.

Colloids Surf B Biointerfaces. 2019 Sep 1;181:756-766. doi: 10.1016/j.colsurfb.2019.06.004. Epub 2019 Jun 17.

PMID:
31234063

Supplemental Content

Loading ...
Support Center